Big Pharma Split Corp Class A (PRM) — Free Cash Flow Generation Index
Big Pharma Split Corp Class A (PRM) has a Free Cash Flow Generation Index of 1.00x as of September 2023. Free cash flow of CA$644.28K represents 1% of operating cash flow (CA$644.28K). Explore PRM capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Big Pharma Split Corp Class A Free Cash Flow Generation Index (2018–2023)
Historical FCF Generation Index trend for Big Pharma Split Corp Class A across 5 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Big Pharma Split Corp Class A.
Annual Free Cash Flow Generation for Big Pharma Split Corp Class A (2018–2023)
Year-by-year Free Cash Flow Generation Index for Big Pharma Split Corp Class A. Check Big Pharma Split Corp Class A (PRM) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CAD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.00x | CA$11.86 Million | CA$11.86 Million | CA$3.00 | ▼ 0.0% |
| 2022 | 1.00x | CA$1.13 Million | CA$1.13 Million | CA$0.00 | ▲ +0.0% |
| 2020 | 1.00x | CA$4.35 Million | CA$4.35 Million | CA$3.00 | ▲ +0.0% |
| 2019 | 1.00x | CA$8.68 Million | CA$8.68 Million | CA$0.00 | ▲ +0.0% |
| 2018 | 1.00x | CA$1.27 Million | CA$1.27 Million | CA$0.00 | — |